✨ Free AI Report
Coeptis Therapeutics Holdings, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Research Preview Coeptis Therapeutics Holdings, Inc.
Research Preview

Coeptis Therapeutics Holdings, Inc.: Business Overview, Financials & Competitive Analysis

Coeptis Therapeutics is a Wexford, Pennsylvania-based biopharmaceutical and technology company focused on developing innovative cell therapy platforms for cancer, autoimmune, and infectious diseases. The company compl...

Analyst-debate audio for Coeptis Therapeutics Holdings, Inc.

AskCyborg analysts argue the bull and bear cases for Coeptis Therapeutics Holdings, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Coeptis Therapeutics Holdings, Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below
3/ 10Weak

Cyborg Score thesis

Early-stage cell therapy biotech with diversified pipeline and recent merger creates high-risk, high-reward profile dependent on...

Read the full analyst-debate transcript →
Industry Immunology Drugs
5 named competitors
2 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 5, 2026
AI-Verified Research
30+ Page Report

Get the Latest Coeptis Therapeutics Holdings, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Coeptis Therapeutics Holdings, Inc. Overview

Pro stress-test →

Coeptis Therapeutics is a Wexford, Pennsylvania-based biopharmaceutical and technology company focused on developing innovative cell therapy platforms for cancer, autoimmune, and infectious diseases. The company completed a business combination with Z Squared and listed on the Nasdaq Global Market under ticker ZSQR, effective April 27, 2026.

Strategic Profile

Pro stress-test →

Through subsidiaries including Coeptis Pharmaceuticals, GEAR Therapeutics, SNAP Biosciences, and Coeptis Technologies, the company focuses on developing cell therapy platforms and related technologies targeting cancer, autoimmune, and infectious diseases. The company operates a technology segment integrating AI-powered solutions to build complementary revenue streams, while maintaining a co-development agreement with Vici Health Sciences for CPT60621, targeting Parkinson's Disease.

Competitive Landscape

Pro stress-test →

Coeptis develops cell therapy platforms for cancer treatment. The company competes in the cell therapy and immunotherapy space against established biotech firms and emerging platforms. Competitors include Gilead Sciences (CAR-T therapy), Juno Therapeutics, and numerous other CAR-T and NK cell therapy developers. Competitive advantage derives from SNAP-CAR platform differentiation and multi-indication pipeline breadth.

Industry Context

Coeptis Therapeutics Holdings, Inc. operates in Immunology Drugs.

Key facts

Founded: 2017 · Headquarters: Wexford, Pennsylvania, US · Employees: 105 · Revenue: $1.4M for FY2025 · Market cap: $102.1M (as of April 2026)

What the analysts stress-tested

The top findings that survived the multi-agent debate for Coeptis Therapeutics Holdings, Inc..

+1 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when Coeptis Therapeutics Holdings, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Gilead SciencesEstablished pharmaceutical company with marketed CAR-T therapies and oncology franchises→Allogene TherapeuticsPublic biotech developing off-the-shelf allogeneic CAR-T therapies for cancer→Bristol-Myers SquibbLarge pharmaceutical company developing CAR-T and cell therapies for oncology through Juno Therapeutics subsidiary→NovartisPharmaceutical company developing CAR-T and cell therapies for cancer including Kymriah→Bluebird BioBiotech company developing CAR-T and gene therapies for cancer and blood disorders→

Compare Coeptis Therapeutics Holdings, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Coeptis Therapeutics Holdings, Inc. operates in Immunology Drugs. See how the rest of the sector scores on the Cyborg framework.

Browse Immunology Drugs research →
NEW · MCP server

Ask your AI assistant about Coeptis Therapeutics Holdings, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Coeptis Therapeutics Holdings, Inc. and its top competitor on Cyborg Score”
“What did Coeptis Therapeutics Holdings, Inc. do this quarter?”
“Is Coeptis Therapeutics Holdings, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Coeptis Therapeutics Holdings, Inc. do?+
Coeptis Therapeutics is a Wexford, Pennsylvania-based biopharmaceutical and technology company focused on developing innovative cell therapy platforms for cancer, autoimmune, and infectious diseases. The company compl...
What is Coeptis Therapeutics Holdings, Inc.'s Cyborg Score?+
Coeptis Therapeutics Holdings, Inc. has a Cyborg Score of 3/10 (Weak). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Coeptis Therapeutics Holdings, Inc.'s main competitors?+
Named competitors include Gilead Sciences, Allogene Therapeutics, Bristol-Myers Squibb, Novartis. The full competitive landscape is in the AskCyborg report.
How can I get the full Coeptis Therapeutics Holdings, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Coeptis Therapeutics Holdings, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Coeptis Therapeutics Holdings, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Immunology Drugs research

Companies in the same sector and named competitors, ranked by Cyborg Score.

7Novartis AG